Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab + methotrexate versus placebo + methotrexate in early persistent oligoarthritis
2008-004877-17Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Mar 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in oligoarthritis comparing Humira + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: Clinical remission at week 24. Started Mar 2011; status: completed.
02
Drugs
adalimumabmethotrexate
03
Conditions
oligoarthritis
Beyond the preview
Go deeper on 2008-004877-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004877-17.